Expertise in
53
conditions

Dr. Gregory J. Gerstner

Hematology
Illinois Cancercare
8940 N Wood Sage Rd, 
Peoria, IL 
Accepting New Patients
Offers Telehealth
Expertise in
53
conditions
Illinois Cancercare
8940 N Wood Sage Rd, 
Peoria, IL 

Overview

Gregory Gerstner is a Hematologist practicing medicine in Peoria, Illinois.

Dr. Gerstner is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 4 clinical trials. Dr. Gerstner is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in AZ

Hospital Affiliations

Osf Saint Elizabeth Mdl Ctr
Carle Health Methodist Hospital
Osf Saint Paul Medical Center
Saint Francis Medical Center
Osf Saint Clare Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Illinois Cancercare
8940 N Wood Sage Rd, Peoria, IL 61615
Other Locations
Illinois Cancer Care PC
4391 Venture Dr, Peru, IL 61354

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
Enrollment Status: Completed
Publish Date: March 18, 2026
Intervention Type: Drug, Device
Study Drug: Immune checkpoint inhibitors or docetaxel
Study Phase: Phase 3
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
A Phase 1/2, Open-Label Study of ADXS-503 Alone and in Combination With Pembrolizumab in Subjects With Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer
A Phase 1/2, Open-Label Study of ADXS-503 Alone and in Combination With Pembrolizumab in Subjects With Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: ADXS-503, Pembrolizumab
Study Phase: Phase 1/Phase 2
Phase II Trial of Daratumumab Retreatment in Patients With Relapsed Multiple Myeloma
Phase II Trial of Daratumumab Retreatment in Patients With Relapsed Multiple Myeloma
Enrollment Status: Withdrawn
Publish Date: June 15, 2022
Intervention Type: Biological, Drug
Study Drugs: Daratumumab, Dexamethasone, Pomalidomide
Study Phase: Phase 2
View 3 Less Clinical Trials

5 Total Publications

Assessing safety and feasibility of virtual reality intervention in patients with lung cancer: a pilot study.
Assessing safety and feasibility of virtual reality intervention in patients with lung cancer: a pilot study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 03, 2024
Similar Doctors
Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

Bleeding And Clotting Disorders Institute

427 W Northmoor Rd, 
Peoria, IL 
 (4.2 miles away)
309-692-5337
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Tarantino is a Hematologist practicing medicine in Peoria, Illinois. Dr. Tarantino is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Blood Clots, Thrombocytopenia, Hemophilia A, and Splenectomy. Dr. Tarantino is currently accepting new patients.

Expertise in
92
conditions
Dr. Michael Veeder
Hematology | Oncology
Expertise in
92
conditions
Dr. Michael Veeder
Hematology | Oncology
Referral may be required

Illinois Cancercare

8940 N Wood Sage Rd, 
Peoria, IL 
 (0.1 miles away)
309-243-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Veeder is a Hematologist and an Oncologist practicing medicine in Peoria, Illinois. Dr. Veeder is highly rated in 92 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Severe Congenital Neutropenia, and Bone Marrow Aspiration. Dr. Veeder is currently accepting new patients.

Expertise in
92
conditions
Dr. Gary R. Macvicar
Hematology | Oncology | Internal Medicine
Expertise in
92
conditions
Dr. Gary R. Macvicar
Hematology | Oncology | Internal Medicine
Referral may be required

Illinois Cancercare, PC

8940 N Wood Sage Rd, 
Peoria, IL 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Macvicar is a Hematologist and an Oncologist practicing medicine in Peoria, Illinois. Dr. Macvicar is highly rated in 92 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Prostate Cancer, Bone Marrow Aspiration, and Orchiectomy. Dr. Macvicar is board certified in American Board Of Internal Medicine. Dr. Macvicar is currently accepting new patients.

Frequently Asked Questions about Dr. Gregory J. Gerstner

How do I make an appointment with Dr. Gregory J. Gerstner?

You can book an appointment with Dr. Gregory J. Gerstner by calling their office at 309-240-6040. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gregory J. Gerstner a top-rated expert for Richter Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory J. Gerstner is classified as an Distinguished expert for Richter Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gregory J. Gerstner specialize in?

While Dr. Gregory J. Gerstner is a Hematology, they have specific expertise in Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), and Follicular Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Gregory J. Gerstner participate in research or clinical trials?

Yes. Dr. Gregory J. Gerstner has published 5 articles and abstracts on conditions like Richter Syndrome. You can view a list of Dr. Gregory J. Gerstner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gregory J. Gerstner accept my insurance?

Dr. Gregory J. Gerstner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 309-240-6040 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gerstner's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 43 Advanced Conditions
    View All 54 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile